ASCI / Young Physician-Scientist Awards, 2022

The Young Physician-Scientist Awards (YPSA) recognize physician-scientists who are early in their first faculty appointment and have made notable achievements in their research.

View all ASCI awards

Floris Barthel, MD
City of Hope Medical Center
(Affiliation at the time of recognition)

About the awardee

Floris Barthel, MD, is an assistant professor at The Translational Genomics Research Institute (TGen; Phoenix, Arizona) and City of Hope (CoH; Duarte, California) where he oversees a cancer genomics laboratory focused on utilizing state-of-the-art genomic approaches to study the development and evolution of glial brain tumors (gliomas). The lab has a particular interest in the fundamental role of telomere dysfunction in glioma development, but is generally interested in all aspects of evolution including but not limited to longitudinal studies of therapy response assessed by genomic analysis of tumor tissue and liquid biopsies. The lab has received both government (eg. National Institutes of Health) and philanthropic funding for several translational and basic science research projects in this domain. Prior to joining TGen/CoH, Dr. Barthel was a postdoctoral fellow at the MD Anderson Cancer Center (Houston, Texas) and the Jackson Laboratory for Genomic Medicine (Farmington, Connecticut). His work has led to numerous publications in top-tier journals including Nature and Cell and played a small part in recent updates to the World Health Organization guidelines for the classification of brain tumors. In addition to primary appointments at CoH and TGen, Dr. Barthel holds adjunct appointments with the School of Life Sciences at the College of Liberal Arts and Sciences at Arizona State University and the Department of Basic Medical Sciences at the University of Arizona College of Medicine. He is the recipient of various awards, including the William Guy Forbeck Research Foundation Scholar Award in 2019 and the Brain Tumor Charity Celebrating You Research Rising Star Award in 2020.